{"id":"W4408531295","doi":"10.3390/curroncol32030169","title":"Q-TWiST Analysis of Sacituzumab Govitecan vs. Chemotherapy in Previously Treated Patients with HR+/HER2− Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Current Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; Servier; Seagen; Clovis Oncology; Eisai; Jazz Pharmaceuticals; National Cancer Institute; Baxalta; F. Hoffmann-La Roche; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Daiichi Sankyo Europe; Bayer HealthCare; Sanofi; Pfizer; Myriad Genetics; Eli Lilly and Company; AstraZeneca; Queen Mary University of London","keywords":"Medicine; Breast cancer; Internal medicine; Metastatic breast cancer; Twist; Cancer; Adverse effect; Oncology; Chemotherapy; Randomization; Population; Quality of life (healthcare); Clinical trial; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002085279,0.000231544,0.0006997378,0.0002477402,0.0001022326,0.0004218078,0.0001718112,0.0002591832,0.001234817],"category_scores_gemma":[0.00257574,0.00009100255,0.002209264,0.0004184106,0.0001885317,0.0003506493,0.0002914437,0.0006747063,0.000107608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005844967,"about_ca_system_score_gemma":0.0003785783,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001258167,"about_ca_topic_score_gemma":0.002160975,"domain_scores_codex":[0.9993191,0.0003525891,0.00005072141,0.00008587779,0.0001005719,0.00009119699],"domain_scores_gemma":[0.9985198,0.0006372988,0.0004973466,0.00006281329,0.00007236678,0.0002103794],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3768004,0.001947407,0.5116148,0.0008224373,0.01090454,0.0002250787,0.0002573472,0.009317131,0.008118906,0.0004876638,0.0009740923,0.07853019],"study_design_scores_gemma":[0.008246709,0.07187708,0.8969694,0.00007970768,0.005866806,0.0002576131,0.0002169003,0.01154963,0.002152762,0.0006399341,0.002088702,0.00005480335],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985974,0.0006409342,0.0001493752,0.00004947013,0.0000119071,0.0000219434,0.0002883107,0.000002666415,0.0002380123],"genre_scores_gemma":[0.9992132,0.0001248666,0.0000855393,0.00004012107,0.00001222293,0.00002167286,0.000355188,0.000001507374,0.0001455481],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002085279,"threshold_uncertainty_score":0.01102817,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02874331636762249,"score_gpt":0.3872256807176728,"score_spread":0.3584823643500503,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}